Artificial Intelligence
China’s 2021 U.S. Patent Grants Surged, Even as Total Patent Awards Trended Downward, According to Analysis by IFI CLAIMS
Enhancements in telemedicine, more hardy grains to feed the world in a time of climate change, and tools to improve the supply chain and better track goods from cargo port to the store shelf or doorstep are among the top corporate R&D priorities over the past year, based on U.S. patent applications compiled and analyzed by IFI CLAIMS Patent Services. The findings are part of IFI’s newly published 2021 U.S. Top 50 and IFI Global 250 patent rankings using its proprietary data platform to make global patent data more accessible.
Total U.S. patent grants declined about 7 percent from 2020, the most precipitous drop in the past decade, according to IFI data. Grants went from 352,000 in 2020 to 327,329 during the past year; published patent applications also saw a slight downtick, about 1 percent, going from 413,173 to 410,093 during that time frame. Highlights from the full analysis and an overview of trends appear on the IFI website.
The Top 50 and related rankings from IFI provide insight into the most innovative companies and R&D organizations. The information is culled by assignee name from thousands of new patent documents daily, and with the data standardized for quick and accurate analysis.
“Last year saw the steepest decline in patent grants in the past decade. There could be many reasons for this – and clearly some are pandemic-related – but what we’re seeing is that corporations are still innovating at an impressive clip despite a challenging environment, particularly U.S. and Asia-based entities,” said Mike Baycroft, CEO of IFI CLAIMS Patent Services.
China Surges, as Others Decline
In a year that saw U.S. patent grants decrease anywhere from 8 to 12 percent among worldwide corporations, China-based companies stood out with an increase of 10 percent, going from 18,792 awards in 2020 to 20,679 during the past year. A total of four Chinese companies are now in the U.S. Top 50 including Huawei at #5, BOE at #11, Advanced New Technologies at #43, and Guangdong Oppo at #49. U.S. company grants were down commensurate with the worldwide total decline, 8.3 percent.
Among the top 10 countries awarded grants, U.S.-based companies stood head-and-shoulders above their international peers in innovating, accounting for more than half of all patent grants by USPTO in 2021. Its 150,801 new grants were 69 percent more than Japan, in second place with 47,105. South Korean (21,264), Chinese (20,679) and German (14,663) companies rounded out the top five grantees by country.
Big Blue on Patents
IBM, the established leader in U.S. patents, once again topped the list, though its 8,682 patent grants was down marginally from the 9,130 grants it earned in 2020. Samsung Electronics maintained its No. 2 spot, with 6,366 grants (down 1 percent from 2020), and Canon, with 3,021 grants, held its No. 3 position. Taiwan Semiconductor, Huawei Technologies, Intel, Apple, LG Electronics, Microsoft Technology Licensing, and Qualcomm rounded out the top 10 patent assignees during the past year.
While the same cast of companies comprised the Top 10 in 2020, Taiwan Semiconductor and Huawei Technologies were the biggest risers in 2021, each moving up four slots on the list. Except for Huawei which added only 9 patents, none of the other top 10 rose from 2020 to 2021, however. To find an increase, you have to go down to No. 13 on the list, Samsung Display Company, which saw a slender rise of 4 percent. The only others to earn more patents in 2021 were Micron Technology (+ 17%), EMC IP Holding Company (+ 14%), and Hewlett Packard Development Company (+ 5%).
Amazon, which slid from No. 11 to No. 14 in the rankings, claimed 1,942 patents last year, significantly down from 2,245 the prior year (- 13 %).
Supply Chain, AI and Vaping Ring Up Patents
As was the case in 2020, the largest category of patent activity in 2021 – a strong indicator of what’s coming down the road – was Computer Systems Based on Biological Models, which saw a 54 percent increase (CAGR) from 2017-21. This hot area of computing uses brain biology as an inspiration and includes Big Tech stalwarts such as IBM, Google, Samsung, Microsoft and Intel. Another area, Flowering Plants, which witnessed such innovations as new soybean, corn and tomato varieties in 2021, saw 42 percent (CAGR) growth in patent awards during that five-year span.
Other hotbeds for new patents included Electrical Smoking Devices (up 40 percent); Machine Learning (up 39 percent); Quantum Computing (up 36 percent); Earth Drilling for Obtaining Oil, Gas or Water (up 36 percent); Computer-Aided Design (up 31 percent); Wireless Network Protocols (up 28 percent); Displays (up 28 percent); and Storing, Control or Detection of Articles in Load Carriers or Conveyors (up 27 percent). To view the full report, visit the 2021 Top 10 Fastest-Growing Technologies published today.
Samsung Leads Total Global Holdings
When it comes to total global patent holdings, Samsung Electronics of South Korea tops the 2021 IFI Global 250 with a portfolio of 90,416 currently held patent families. If you count corporate entities, the U.S. leads the global list with 70 companies in the top 250, Japan is second with 51, and China is third with 46. However, China’s growing patent dominance is reflected by holding six of the top 10 slots while the U.S. holds only one, IBM at #8. China’s Chinese Academy of Sciences is #2 with 78,415, Midea Group is #3 with 58,495 and Huawei Investment and Holding Co. is #4 with 48,307. Japan’s Canon is ninth with 40,706 and Panasonic tenth with 37,538.
If you consider the size of the portfolios, China holds nearly one in three or 29 percent of the Global 250 patent families compared to the U.S. (24 percent) and Japan (19 percent). Deeper analysis shows that U.S. and Japan portfolios are stronger and more mature, nevertheless it is clear that China has stimulated an R&D culture that is serious about intellectual property, according to Baycroft.
Patent activity is a valuable financial indicator for researchers, analysts, and investors who seek insight into companies’ R&D productivity and clues to IP strategy, as well as technology trends and the competitive landscape within various industries. Often the true value of a company lies with its intellectual properties. Examining patent assets is a key tool in gauging the intangible assets of publicly traded companies.
To create your own analysis, visit the IFI CLAIMS Live 1000, a free tool which uses data from the top 1000 companies that received U.S. patents. The tool shows live data and offers interactive features that allow users to create and sort their own lists using a variety of filters.
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
-
Uncategorized7 days agoDFI’s Latest Compact Industrial Computer Equipped with AI Acceleration Module
-
Uncategorized7 days ago
DFI Amplifies AI Capability for the Thriving EV Market and Beyond
-
Artificial Intelligence4 days agoSilent Eight secures AIA as its latest client
-
Artificial Intelligence4 days agoGlobal Networking Innovator Huawei Leads the New Era of Campus Network Technology
